Dual-chamber pacemaker is a small, battery-operated medical device. It is placed inside the chest of a patient suffering from arrhythmia (abnormal heart rhythm). A dual-chamber pacemaker has two leads, one of which is placed in the right ventricle and the other is placed in the right atrium. After slow natural heart rate is detected, the sequential physiological contraction of ventricles and atria is imitated by synchronous action of the two leads. The pacemaker assists the heart to beat at a normal rate by using electric pulses. Arrhythmia increases chances of cardiac stroke, cardiac arrest, and heart attack. According to the Centers for Disease Control and Prevention (CDC), in the U.S., every 40 seconds, an individual suffers a heart attack and every year, 790,000 individuals suffer a heart attack. Among these, 580,000 Americans suffer a heart attack for the first time and 210,000 Americans suffer a heart attack, which is not their first experience. Heart disease is one of the leading causes of death in women as well as men. In 2015, more than 50% of men died due to a heart attack.
Increasing geriatric population leads to the rise in demand for dual-chamber pacemakers. Heart failure is one of the major factors driving the global dual-chamber pacemakers market. It is caused by various reasons including diabetes, high blood pressure, and coronary heart disease. According to the CDC, in 2009, in the U.S., one out of 9 deaths was caused by heart failure and approximately 5.7 million adults suffered from heart failure. The U.S. suffers high cost due to heart failures, which is approximately US$ 30.7 Bn every year. This cost includes the cost of missed days of work of patients, medications to treat heart failure, and cost of health care services. Approximately 50% of patients diagnosed with heart failure die within five years. Technological advancements in the research and development of dual-chamber pacemakers are driving the global dual-chamber pacemakers market. Stringent regulatory reforms restrain the market, as major manufacturers of dual-chamber pacemakers may face difficulty in introducing an innovative product into the market.
The global dual-chamber pacemakers market can be segmented in terms of product type, end-user, and region. In terms of product type, the market can be categorized into conventional type and advanced type dual-chamber pacemakers. Based on end-user, the market can be segmented into hospitals and specialized clinics.
Geographically, the global dual-chamber pacemakers market can be classified into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. North America is anticipated to hold a major market share during the forecast period, due to technological advancements, high disposable income, and increasing geriatric population in the region. Obesity; lack of exercise; consuming foods high in sodium, cholesterol, and fats; and smoking tobacco have led to growth of the global dual-chamber pacemakers market. The market in Asia Pacific is expected to expand significantly during the forecast period, led by increasing government initiatives and awareness about dual-chamber pacemakers in the region.
Key players operating in the global dual-chamber pacemakers market include BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Medtronic, St. Jude Medical, LLC, LivaNova PLC, and lepumedical.com.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.